BRUSSELS (Reuters) – Belgo-Dutch medical supplies company Arseus has lined up big acquisitions early in 2013 to boost its pharmaceutical ingredients business after the latest in a string of smaller bolt-on purchases. The specialist in supplying ingredients for medical compounding, allowing pharmacists to make their own versions of drugs, announced the relatively small purchase on Thursday of Colorado-based B&B Pharmaceuticals. It followed three acquisitions last month worth a total of about 16.5 million euros ($ 21.88 million). …
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Tuesday, December 25, 2012
Arseus sees big drug compounding buys after U.S. add-on
BRUSSELS (Reuters) – Belgo-Dutch medical supplies company Arseus has lined up big acquisitions early in 2013 to boost its pharmaceutical ingredients business after the latest in a string of smaller bolt-on purchases. The specialist in supplying ingredients for medical compounding, allowing pharmacists to make their own versions of drugs, announced the relatively small purchase on Thursday of Colorado-based B&B Pharmaceuticals. It followed three acquisitions last month worth a total of about 16.5 million euros ($ 21.88 million). …
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment